Modification of Abdominal Fat Distribution After Aromatase Inhibitor Therapy in Breast Cancer Patients Visualized Using 3-D Computed Tomography Volumetry

2014 ◽  
Vol 14 (5) ◽  
pp. 365-370 ◽  
Author(s):  
Sofia Battisti ◽  
Francesco Maria Guida ◽  
Federica Coppa ◽  
Donata M. Vaccaro ◽  
Daniele Santini ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Computed Tomography ◽  
Aromatase Inhibitor ◽  
Cancer Patients ◽  
Fat Distribution ◽  
Abdominal Fat ◽  
Inhibitor Therapy ◽  
Breast Cancer Patients ◽  
Aromatase Inhibitor Therapy ◽  
Computed Tomography Volumetry

FLT-PET (Fluorothymidine) and Ki-67 to measure effects of a short course of aromatase inhibitor therapy in ER+ breast cancer patients.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e22161-e22161
Author(s):  
Hannah M. Linden ◽  
Lanell Peterson ◽  
Brenda F. Kurland ◽  
Alena Novakova ◽  
Andrew Shields ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Aromatase Inhibitor ◽  
Cancer Patients ◽  
Inhibitor Therapy ◽  
Breast Cancer Patients ◽  
Ki 67 ◽  
Aromatase Inhibitor Therapy ◽  
Flt Pet ◽  
Short Course

Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy

2011 ◽  
Vol 130 (2) ◽  
pp. 569-577 ◽  
Author(s):  
Lisa Gallicchio ◽  
Ryan MacDonald ◽  
Bethany Wood ◽  
Errol Rushovich ◽  
Kathy J. Helzlsouer
Keyword(s):  
Breast Cancer ◽  
Aromatase Inhibitor ◽  
Cancer Patients ◽  
Inhibitor Therapy ◽  
Musculoskeletal Symptoms ◽  
Breast Cancer Patients ◽  
Aromatase Inhibitor Therapy
Sign in / Sign up

Export Citation Format

Share Document